|
| Â Â |
| Â | Data Sheet |
 | | Glibenclamide is also contra-indicated in patients with known hypersensitivity or allergy to the drug. |  | | Allergic skin reactions to sulphonylureas such as pruritus, erythema, urticaria, and erythematous, maculopapular and bullous skin eruptions or psoriasiform drug eruption occur in 1.5% of treated patients. |  | | Glibenclamide should not be given as sole therapy to patients with unstable and/or insulin-dependent diabetes mellitus (Type I) patients with ketoacidosis or diabetic coma |
|
http://www.medsafe.govt.nz/profs/datasheet/a/Apoglibenclamidetab.htm
|
|
| Â Â |
| Â | Aloe Information from eVitamins |
 | | However, a large, modern, placebo-controlled trial did not find aloe effective for treating minor burns. |  | | Two small controlled human trials have found that aloe, either alone or in combination with the oral hypoglycemic drug, glibenclamide, effectively lowers blood sugar in people with type 2 (non-insulin-dependent) diabetes. |  | | An aloe extract in a cream has been shown effective in a double-blind, controlled trial in people with psoriasis. |
|
http://www.evitamins.com/healthnotes/healthnotes.asp?ContentID=2036003
|
|
| Â Â |
| Â | Glibenclamide binding to sulphonylurea receptor subtypes: dependence on adenine nucleotides -- Hambrock et al. 136 (7): ... |
 | | -methyleneadenosine 5'-triphosphate; ARS, ATP-regenerating system; GBC, glibenclamide; HEK cells, human embryonic kidney cells; K |  | | are the target of the hypoglycaemic sulphonylureas like glibenclamide. |  | | Keywords: Sulphonylurea receptor subtypes; SUR2(Y1206S) mutants with high affinity for glibenclamide; glibenclamide binding to SUR; adenine nucleotides and glibenclamide binding; ATP-consuming system; ATP-regenerating system; effect of Kir6.2 on glibenclamide binding to SUR; synergy and cooperativity |
|
http://www.brjpharmacol.org/cgi/content/abstract/136/7/995
|
|
|